logo

Established since 1951, we provide a full range of services as a CDMO for Live biotherapeutic products (LPB).

Contact us

+33 4 71 46 80 00

info@biose.com

24 Avenue Georges Pompidou, 15000 Aurillac, France

Mon - Frid, 8 AM - 5 PM

Closed on Saturday - Sunday.

The Biose Industrie Story

The Biose Industrie Story

1951

Biose Industrie was founded in 1951 under the name Lyocenter Laboratories to specialize in manufacturing bacteria as a drug

Biose Industrie was founded in 1951 under the name Lyocenter Laboratories to specialize in manufacturing  bacteria as a drug

The 1940s and 1950s were known as a ‘golden age’ of microbiology, with scientists making major advances in knowledge about bacteria as well as the development of many life-saving antibiotic drugs: penicillin, streptomycin, and tetracycline. After World War II, scientists also wanted to develop drug products that would supply beneficial..Read More

1970

Between 1970 and 1975, the company moved to a new site that still serves its needs decades later

Between 1970 and 1975, the company moved to a new site that still serves its needs decades later

During its first two decades, Biose Industrie served a steady lineup of clients in bugs as drugs industry. The company leadership had the ambition to become the top global CDMO for live biotherapeutic products but knew the organisation would soon outgrow its existing facility located in an isolated area north..Read More

1997

New owners bring increased focus on microbes as drugs

New owners bring increased focus on microbes as drugs

French family takes ownership as company begins its ascent to top global CDMO for live biotherapeutic products Biose Industrie manufactured several types of drugs throughout the 1970s and 1980s, having broad capabilities under the ownership of the Reti Group and then AzkoNobel. But it was under the leadership of its..Read More

2020

Biose Industrie Raises EUR 30M to Strengthen its Position as the Reference CDMO in the Field of Microbiota

Biose Industrie Raises EUR 30M to Strengthen its Position as the Reference CDMO in the Field of Microbiota

Aurillac, July 16, 2020 – Biose Industrie announced today the closing of a €30 million funding round led by Cathay Capital, alongside the company’s management team, banking partners and the Auvergne-Rhône-Alpes region. Thanks to this funding found, Biose Industrie will benefit from Cathay Capital’s support as it accelerates its development..Read More